NCT01485146View on ClinicalTrials.gov

A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 25, 2011

Primary Completion Date

January 25, 2012

Study Completion Date

January 25, 2012

Conditions
Safety Evaluation of Escalating Doses
Interventions
DRUG

ETC-1002

escalating doses

Trial Locations (1)

49007

Jasper Clinic, Inc., Kalamazoo

Sponsors
All Listed Sponsors
lead

Esperion Therapeutics, Inc.

INDUSTRY